The choice of the noninferiority margin in clinical trials was driven by baseline risk, type of primary outcome, and benefits of new treatment
Published in
Journal of clinical epidemiology, vol. 68, no. 10, p. 1144-1151Publication date
2015Abstract
Keywords
- Adult
- Confidence Intervals
- Cross-Sectional Studies
- Female
- Humans
- Male
- Middle Aged
- Models, Statistical
- Randomized Controlled Trials as Topic
- Research Personnel/psychology
- Sample Size
- Surveys and Questionnaires
- Treatment Outcome
UNIGE research groups
Citation (ISO format)
GAYET-AGERON, Angèle et al. The choice of the noninferiority margin in clinical trials was driven by baseline risk, type of primary outcome, and benefits of new treatment. In: Journal of clinical epidemiology, 2015, vol. 68, n° 10, p. 1144–1151. doi: 10.1016/j.jclinepi.2015.01.017
Main files (1)
Article (Published version)
Identifiers
- PID : unige:90339
- DOI : 10.1016/j.jclinepi.2015.01.017
- PMID : 25716902
